145 related articles for article (PubMed ID: 35921255)
1. Urinary excretion profile of prednisolone and prednisone after rectal administration: Significance in antidoping analysis.
Iannella L; Comunità F; Botrè F; Colamonici C; Curcio D; de la Torre X; Mazzarino M
Drug Test Anal; 2022 Nov; 14(11-12):2007-2016. PubMed ID: 35921255
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion profile of prednisone and prednisolone after different administration routes.
Mazzarino M; Piantadosi C; Comunità F; de la Torre X; Botrè F
Drug Test Anal; 2019 Nov; 11(11-12):1601-1614. PubMed ID: 31701669
[TBL] [Abstract][Full Text] [Related]
3. Elimination profiles of prednisone and prednisolone after different administration routes: Evaluation of the reporting level and washout periods to ensure safe therapeutic administrations.
Coll S; Monfort N; Alechaga É; Matabosch X; Pozo OJ; Pérez-Mañá C; Ventura R
Drug Test Anal; 2021 Mar; 13(3):571-582. PubMed ID: 33161623
[TBL] [Abstract][Full Text] [Related]
4. Carbon isotopic characterization of prednisolone and prednisone pharmaceutical formulations: Implications in antidoping analysis.
Iannella L; Botrè F; Colamonici C; Curcio D; Ciccarelli C; Mazzarino M; de la Torre X
Drug Test Anal; 2020 Nov; 12(11-12):1587-1598. PubMed ID: 32529794
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a method to confirm the exogenous origin of prednisone and prednisolone by GC-C-IRMS.
Iannella L; Botrè F; Colamonici C; Curcio D; de la Torre X
Drug Test Anal; 2019 Nov; 11(11-12):1615-1628. PubMed ID: 31655496
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the urinary excretion of prednisolone and metabolites after nasal administration: Relevance to doping control.
Deventer K; Polet M; Van Gansbeke W; Hooghe F; Van Hoecke H; Van Eenoo P
Drug Test Anal; 2021 Nov; 13(11-12):1897-1905. PubMed ID: 34081842
[TBL] [Abstract][Full Text] [Related]
7. Detection and characterization of prednisolone metabolites in human urine by LC-MS/MS.
Matabosch X; Pozo OJ; Pérez-Mañá C; Papaseit E; Segura J; Ventura R
J Mass Spectrom; 2015 Mar; 50(3):633-42. PubMed ID: 25800201
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous identification of prednisolone and its ten metabolites in human urine by high performance liquid chromatography-tandem mass spectrometry.
Ahi S; Beotra A; Dubey S; Upadhyay A; Jain S
Drug Test Anal; 2012 Jun; 4(6):460-7. PubMed ID: 22354815
[TBL] [Abstract][Full Text] [Related]
9. Elimination profiles of betamethasone after different administration routes: Evaluation of the reporting level and washout periods to ensure safe therapeutic administrations.
Coll S; Monfort N; Alechaga É; Matabosch X; Pérez-Mañá C; Ventura R
Drug Test Anal; 2021 Feb; 13(2):348-359. PubMed ID: 32949107
[TBL] [Abstract][Full Text] [Related]
10. Iatrogenic Cushing syndrome in 24-hour urine free cortisol measurement.
Ray JA; Bajaj AO; Trier EK; Johnson LM
Clin Chim Acta; 2022 Sep; 534():173-175. PubMed ID: 35931175
[TBL] [Abstract][Full Text] [Related]
11. A field survey on the presence of prednisolone and prednisone in urine samples from untreated cows.
Vincenti M; Leporati M; Capra P; Gatto S; Attucci A; Barbarino G; Nebbia C
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2012; 29(12):1893-900. PubMed ID: 22963583
[TBL] [Abstract][Full Text] [Related]
12. Suitability of bovine bile compared to urine for detection of free, sulfate and glucuronate boldenone, androstadienedione, cortisol, cortisone, prednisolone, prednisone and dexamethasone by LC-MS/MS.
Chiesa L; Nobile M; Panseri S; Vigo D; Pavlovic R; Arioli F
Food Chem; 2015 Dec; 188():473-80. PubMed ID: 26041220
[TBL] [Abstract][Full Text] [Related]
13. A simplified procedure for the analysis of formoterol in human urine by liquid chromatography-electrospray tandem mass spectrometry: application to the characterization of the metabolic profile and stability of formoterol in urine.
Mazzarino M; de la Torre X; Fiacco I; Pompei C; Calabrese F; Botrè F
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jul; 931():75-83. PubMed ID: 23777613
[TBL] [Abstract][Full Text] [Related]
14. Determination of unbound prednisolone, prednisone and cortisol in human serum and saliva by on-line solid-phase extraction liquid chromatography tandem mass spectrometry and potential implications for drug monitoring of prednisolone and prednisone in saliva.
Ruiter AF; Teeninga N; Nauta J; Endert E; Ackermans MT
Biomed Chromatogr; 2012 Jul; 26(7):789-96. PubMed ID: 22020542
[TBL] [Abstract][Full Text] [Related]
15. Budesonide use and misuse in sports: Elimination profiles of budesonide and metabolites after intranasal, high-dose inhaled and oral administrations.
Coll S; Monfort N; Matabosch X; Papakonstantinou K; Pérez-Mañá C; Mateus JA; Ventura R
Drug Test Anal; 2020 May; 12(5):629-636. PubMed ID: 31306564
[TBL] [Abstract][Full Text] [Related]
16. Identification of budesonide metabolites in human urine after oral administration.
Matabosch X; Pozo OJ; Pérez-Mañá C; Farré M; Marcos J; Segura J; Ventura R
Anal Bioanal Chem; 2012 Aug; 404(2):325-40. PubMed ID: 22573060
[TBL] [Abstract][Full Text] [Related]
17. Profile of the urinary excretion of prednisolone and its metabolites in finishing bulls and cows treated with a therapeutic schedule.
Nebbia C; Capra P; Leporati M; Girolami F; Barbarino G; Gatto S; Vincenti M
BMC Vet Res; 2014 Sep; 10():237. PubMed ID: 25267433
[TBL] [Abstract][Full Text] [Related]
18. Effects of cimetidine and ranitidine on the conversion of prednisone to prednisolone.
Sirgo MA; Rocci ML; Ferguson RK; Eshelman FN; Vlasses PH
Clin Pharmacol Ther; 1985 May; 37(5):534-8. PubMed ID: 3987177
[TBL] [Abstract][Full Text] [Related]
19. A pharmacokinetic comparison of two oral liquid glucocorticoid formulations.
Kamada AK; Wiener MB; LaVallee NM; Scott MB; Selner JC; Szefler SJ
Pharmacotherapy; 1997; 17(2):353-6. PubMed ID: 9085328
[TBL] [Abstract][Full Text] [Related]
20. A preliminary study on urinary excretion patterns of methylprednisolone after oral and intra-articular administration and effect on endogenous glucocorticosteroids profile.
Upadhyay AK; Dubey S; Ahi S; Beotra A; Bhardwaj A; Shukla S; Jain S
Indian J Pharmacol; 2021; 53(6):480-483. PubMed ID: 34975136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
